Insulin Pen Needles - Global Market Trajectory & Analytics

Global Insulin Pen Needles Market to Reach $3.4 Billion by 2027

Amid the COVID-19 crisis, the global market for Insulin Pen Needles estimated at US$2.1 Billion in the year 2020, is projected to reach a revised size of US$3.4 Billion by 2027, growing at a CAGR of 6.7% over the period 2020-2027. Standard Insulin Pen Needles, one of the segments analyzed in the report, is projected to record 6.3% CAGR and reach US$2.2 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Safety-Engineered Insulin Pen Needles segment is readjusted to a revised 7.5% CAGR for the next 7-year period.





The U.S. Market is Estimated at $579.7 Million, While China is Forecast to Grow at 10.2% CAGR

The Insulin Pen Needles market in the U.S. is estimated at US$579.7 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$732.4 Million by the year 2027 trailing a CAGR of 10.2% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.7% and 6% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Select Competitors (Total 43 Featured):

• Becton, Dickinson & Company
• Htl-Strefa S.A.
• MedExel Co., Ltd.
• Novo Nordisk, Inc.
• Owen Mumford Ltd.
• Vogt Medical Vertrieb GmbH